The global diabetic foot ulcers treatment market is estimated to be valued at US$ 7.72 Bn in 2024 and is expected to exhibit a CAGR of 10.% over the forecast period 2023 to 2030. Diabetic foot ulcers are one of the major complications arising from diabetes mellitus and require proper medical treatment. Treatment of diabetic foot ulcers involves regular dressing, debridement of dead tissue, infection treatment, offloading pressure and use of advanced treatment options like skin grafting, hyperbaric oxygen therapy, and bio-engineered skin substitutes. Factors such as rising geriatric population, increasing prevalence of diabetes, growth in healthcare expenditure and technological advancements in treatment options are fueling the growth of the diabetic foot ulcers treatment market globally.
Key Takeaways
Key players operating in the diabetic foot ulcers treatment market are 3M Healthcare, Braun Melsungen AG, Smith & Nephew, Inc., Organogenesis, Inc., Derma Sciences Inc., Sigvaris Inc., Acelity L.P. Inc., Osiris, Molnlycke Health Care AB, Alkem Laboratories Ltd., Healthium Medtech, Kerecis, Podimetrics, Carmell Corporation, Paracrine, Inc., VIVEX Biologics, Inc., and PolarityTE, Inc. The key players are involved in new product launches and strategic collaborations to strengthen their market position. Rising prevalence of diabetes across the globe has increased the number of patients suffering from foot ulcer complications requiring advanced treatment protocols. Technological advancements in bioengineered skin substitutes, smart wound dressings and negative pressure wound therapy devices have improved wound healing and patient outcomes.
Market Trends
Increased Adoption of Advanced Wound Care Products: Advanced wound care products like skin/biosynthesis substitutes, smart wound dressings and negative pressure wound therapy devices provide improved healing for chronic, non-healing ulcers and are being increasingly adopted.
Growing Popularity of E-health and Telemedicine Solutions: E-health and telemedicine solutions that enable remote patient monitoring and virtual consultations are gaining popularity. This trend is expected to continue over the forecast period.
Market Opportunities
Growing Healthcare Market in Emerging Countries: Emerging countries in Asia Pacific and Latin America regions are witnessing rapid economic growth and improving healthcare infrastructure offering lucrative opportunities.
Increasing Research on Stem Cell and Tissue Engineering Therapies: Active research on stem cell and tissue engineering therapies for regeneration of tissues offers promising treatment alternatives in future.
Impact of COVID-19 on Diabetic Foot Ulcers Treatment Market growth
The COVID-19 pandemic has significantly impacted the growth of the diabetic foot ulcers treatment market. In the initial phase of the pandemic, a shift was witnessed from elective to emergency care, which led to the postponement of various elective surgeries and outpatient appointments for diabetic foot ulcer treatment. This resulted in a decline in new patient registrations and sales of related products in 2020. However, as the pandemic situation stabilizes, awareness regarding preventive foot care for diabetes patients increased among individuals as well as healthcare providers. Post-COVID, the market is expected to witness steady growth driven by increasing diabetes prevalence, aging population, healthcare reforms supporting home healthcare, and expanding product offerings from key players. Market players are focusing on telehealth and remote monitoring solutions to aid continuous follow-ups. Advancements in wound care therapies using regenerative medicines, skin/tissue substitutes, and biosimilars will further support growth.
Geographic regions with significant Diabetic Foot Ulcers Treatment market value
North America currently dominates the global diabetic foot ulcers treatment market in terms of value, accounting for over 40% share. This can be attributed to the increasing diabetic population, favorable reimbursement policies, technological advancements, and presence of prominent players. The Asia Pacific region is projected to be the fastest growing market during the forecast period supported by improving healthcare infrastructure, rising medical tourism, growing penetration of health insurance, and economic development in various countries. The LATAM region presents lucrative opportunities as well due to increasing government focus on diabetes management. Europe holds second position in terms of market size, while Middle East & Africa provides scope for further expansion.
